Loading markets…

Arcutis Biotherapeutics, Inc. (ARQT) forecast

Arcutis Biotherapeutics, Inc. (ARQT) forecast: price $32.12, trailing P/E 148.64, forward P/E 66.24. How to read the street's path.

$32.12Price
$4.04BMarket cap
148.64P/E ?
66.24Forward P/E ?
0.00%Dividend yield ?

The live ARQT price is $32.12. Trailing P/E is 148.64 and forward P/E is 66.24. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the ARQT forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full ARQT quote · Dividends · Price prediction · Academy

Questions

What is ARQT's forward P/E?

The latest forward P/E on Stocklytics is 66.24, against a trailing P/E of 148.64 and a price of $32.12.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.